Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 17 January 2017 |
| Author/s |
author: Rémi Rabasa-Lhoret |
| Publication date | January 17, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |